Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Westlake BioPartners is a venture capital firm based in Los Angeles, specializing in life sciences. Founded to bolster the biotech ecosystem, the firm manages a concentrated portfolio, allowing for personalized attention to its investments. They focus on pre-seed, seed, and Series A stages, with a total of seven companies in their portfolio.
This firm invests in the life sciences sector, particularly in the development of new medicines. Westlake BioPartners emphasizes a people-first approach, working closely with entrepreneurs throughout the company formation and growth process. Their investment strategy is designed to provide access to innovation, capital, and community resources.
Notable portfolio companies include AllRock Bio, a clinical-stage company developing a small molecule pan-ROCK inhibitor; 3T Biosciences, focused on next-generation immunotherapy; Arsenal, targeting solid tumor therapies with programmable cell therapy; Borealis Biosciences, advancing RNA medicines for kidney diseases; Capsida, engineering novel AAVs for gene therapies; Electra, developing therapies for immunological diseases; and Kyverna, working on cell therapies for autoimmune diseases.
To pitch Westlake BioPartners, submit your deck through their website's contact form.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.